Follow
Barbara Lovász
Barbara Lovász
Semmelweis University
No verified email
Title
Cited by
Cited by
Year
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between …
PL Lakatos, PA Golovics, G David, T Pandur, Z Erdelyi, A Horvath, ...
Official journal of the American College of Gastroenterology| ACG 107 (4 …, 2012
2402012
Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases: a prospective, multicentre, nationwide cohort
KB Gecse, BD Lovász, K Farkas, J Banai, L Bene, B Gasztonyi, ...
Journal of Crohn's and Colitis 10 (2), 133-140, 2016
2182016
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in …
LS Kiss, T Szamosi, T Molnar, P Miheller, L Lakatos, A Vincze, K Palatka, ...
Alimentary pharmacology & therapeutics 34 (8), 911-922, 2011
1852011
Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort
PL Lakatos, Z Vegh, BD Lovasz, G David, T Pandur, Z Erdelyi, I Szita, ...
Inflammatory bowel diseases 19 (5), 1010-1017, 2013
1292013
Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis
K Farkas, M Rutka, PA Golovics, Z Végh, BD Lovász, T Nyári, KB Gecse, ...
Journal of Crohn's and Colitis 10 (11), 1273-1278, 2016
942016
Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
MD Michael, A Bálint, BD Lovász, L Gulácsi, B Strbák, PA Golovics, ...
The European Journal of Health Economics 15, 121-128, 2014
802014
New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe
BD Lovasz, PA Golovics, Z Vegh, PL Lakatos
Digestive and Liver Disease 45 (4), 269-276, 2013
802013
Evolution of disease phenotype in adult and pediatric onset Crohn’s disease in a population-based cohort
BD Lovasz, L Lakatos, A Horvath, I Szita, T Pandur, M Mandel, Z Vegh, ...
World Journal of Gastroenterology: WJG 19 (14), 2217, 2013
782013
Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe
Z Kurti, BD Lovasz, MD Mandel, Z Csima, PA Golovics, BD Csako, ...
World journal of gastroenterology: WJG 21 (21), 6728, 2015
702015
Inflammatory bowel disease course in Crohn’s disease: is the natural history changing?
PA Golovics, MD Mandel, BD Lovasz, PL Lakatos
World Journal of Gastroenterology: WJG 20 (12), 3198, 2014
612014
Long-term efficacy, safety, and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort
L Gonczi, KB Gecse, Z Vegh, Z Kurti, M Rutka, K Farkas, PA Golovics, ...
Inflammatory bowel diseases 23 (11), 1908-1915, 2017
572017
Prediction of short-and medium-term efficacy of biosimilar infliximab therapy. Do trough levels and antidrug antibody levels or clinical and biochemical markers play the more …
L Gonczi, Z Vegh, PA Golovics, M Rutka, KB Gecse, R Bor, K Farkas, ...
Journal of Crohn's and Colitis 11 (6), 697-705, 2017
572017
Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease
Z Vegh, Z Kurti, L Gonczi, PA Golovics, BD Lovasz, I Szita, M Balogh, ...
Scandinavian journal of gastroenterology 51 (7), 848-854, 2016
562016
Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012
PA Golovics, L Lakatos, MD Mandel, BD Lovasz, Z Vegh, Z Kurti, I Szita, ...
World Journal of Gastroenterology: WJG 21 (23), 7272, 2015
502015
Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: a population-based study based on the National Health Insurance Fund database
Z Kurti, Z Vegh, PA Golovics, P Fadgyas-Freyler, KB Gecse, L Gonczi, ...
Digestive and liver disease 48 (11), 1302-1307, 2016
482016
Is early limited surgery associated with a more benign disease course in Crohn’s disease?
PA Golovics, L Lakatos, A Nagy, T Pandur, I Szita, M Balogh, C Molnar, ...
World Journal of Gastroenterology: WJG 19 (43), 7701, 2013
482013
Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011
BD Lovasz, L Lakatos, A Horvath, T Pandur, Z Erdelyi, M Balogh, ...
Digestive and Liver Disease 46 (5), 405-411, 2014
452014
Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary.
BD Lovasz, L Lakatos, PA Golovics, G David, T Pandur, Z Erdelyi, ...
Journal of Gastrointestinal & Liver Diseases 22 (3), 2013
432013
Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists
P Baji, L Gulácsi, BD Lovász, PA Golovics, V Brodszky, M Péntek, ...
Scandinavian Journal of Gastroenterology 51 (1), 22-27, 2016
392016
The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe
PL Lakatos, BD Lovasz, G David, T Pandur, Z Erdelyi, G Mester, M Balogh, ...
Journal of Crohn's and Colitis 7 (5), 385-391, 2013
352013
The system can't perform the operation now. Try again later.
Articles 1–20